tradingkey.logo

Walmart to replace Astrazeneca on Nasdaq-100 on Jan 20

ReutersJan 10, 2026 1:50 AM

- Walmart WMT.O will replace British drugmaker AstraZeneca AZN.L in the Nasdaq-100 Index on January 20, the exchange operator NDAQ.O said on Friday.

The retail giant said in November it would shift its longtime listing on the New York Stock Exchange to its main rival.

Companies typically change listing venues when they see better alignment with an exchange's investor base, technology and services, or when they want to cut costs tied to listing and compliance.

Some companies that transferred from NYSE to Nasdaq in 2025 cited as a key reason the attractiveness of the Nasdaq-100 index - which includes 100 of the most valuable non-financial companies listed on the Nasdaq, including Nvidia NVDA.O and Apple AAPL.O.

Walmart will replace AstraZeneca in the Nasdaq-100 Index, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index, before market open on January 20, Nasdaq said in a statement.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI